For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The closing price of AEON Biopharma Inc (AMEX: AEON) was $0.50 for the day, up 1.40% from the previous closing price of $0.49. In other words, the price has increased by $1.40 from its previous closing price. On the day, 0.83 million shares were traded.
Ratios:
Our analysis of AEON’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.43 and its Current Ratio is at 1.43.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on August 18, 2023, initiated with a Buy rating and assigned the stock a target price of $18.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 29 ’24 when Oleg Grodnensky bought 201,825 shares for $2.63 per share.
Valuation Measures:
As of this moment, AEON’s Price-to-Earnings (P/E) ratio for their current fiscal year is 0.00.
Stock Price History:
Over the past 52 weeks, AEON has reached a high of $269.28, while it has fallen to a 52-week low of $0.38. The 50-Day Moving Average of the stock is -6.78%, while the 200-Day Moving Average is calculated to be -98.59%.
Shares Statistics:
A total of 10.54M shares are outstanding, with a floating share count of 8.24M. Insiders hold about 27.08% of the company’s shares, while institutions hold 14.91% stake in the company.